ERBB2 and ductal breast carcinoma in situ: Notch3. Expression of oncogenic Notch3 in mice leads to mammary cancer (111), and is involved in: hormone-receptor positive breast cancer (120), the proliferation of HER2− breast cancer (147) and HER2+ DCIS (148), and TNBC (149).